Disease-modifying therapies linked to increased risk of cervical lesions in womenPublished: 08 November 2022 Taking high-efficacy disease-modifying therapies (DMTs) is linked with an increased risk of abnormalities of the cervix in females with multiple sclerosis (MS), new research suggests. This information is consistent with other research which has associated DMTs